Xenon Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Xenon Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker XENE.
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials...
Can you invest in Xenon Pharmaceuticals Inc.?
Yes. Xenon Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker XENE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Xenon Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.